Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

DSpace Repository

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

Author: White, Michael T.; Verity, Robert; Griffin, Jamie T.; Asante, Kwaku Poku; Owusu-Agyei, Seth; Greenwood, Brian; Drakeley, Chris; Gesase, Samwel; Lusingu, John; Ansong, Daniel; Adjei, Samuel; Agbenyega, Tsiri; Ogutu, Bernhards; Otieno, Lucas; Otieno, Walter; Agnandji, Selidji T.; Lell, Bertrand; Kremsner, Peter; Hoffman, Irving; Martinson, Francis; Kamthunzu, Portia; Tinto, Halidou; Valea, Innocent; Sorgho, Hermann; Oneko, Martina; Otieno, Kephas; Hamel, Mary J.; Salim, Nahya; Mtoro, Ali; Abdulla, Salim; Aide, Pedro; Sacarlal, Jahit; Aponte, John J.; Njuguna, Patricia; Marsh, Kevin; Bejon, Philip; Riley, Eleanor M.; Ghani, Azra C.
Tübinger Autor(en):
Agnandji, Selidji Todagbe
Lell, Bertrand
Kremsner, Peter
Published in: Lancet Infectious Diseases (2015), Bd. 15, H. 12, S. 1450-1458
Verlagsangabe: Elsevier Sci Ltd
Language: English
Full text: http://dx.doi.org/10.1016/S1473-3099(15)00239-X
ISSN: 1474-4457
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)